Potential Benefits Drive Interest in Continuous Manufacturing

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-05-15-2014
Volume 2014 eBook
Issue 2

Players across the biologics value chain are attracted by the advantages of continuous biopharmaceutical manufacturing.

Players across the biologics value chain are attracted by the advantages of continuous biopharmaceutical manufacturing.

Download

Pharmaceutical Technology’s 2014 Bioprocessing and Sterile Manufacturing eBook

.

 

 

 

 

 

 

 

 

Recent Videos
Jens Schmidt, associate director MSAT at Lonza
Behind the Headlines episode 8
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Roger Viney, PhD, chief commercial officer for ICE Pharma
Related Content